Abstract
On the basis of emerging evidence from patients with COVID-19, we postulate that endothelial cells are essential contributors to the initiation and propagation of severe COVID-19. Here, we discuss current insights into the link between endothelial cells, viral infection and inflammatory changes and propose novel therapeutic strategies.
MeSH terms
-
COVID-19
-
Clinical Trials as Topic
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / pathology*
-
Cytokine Release Syndrome / pathology
-
Cytokines / immunology
-
Drug Delivery Systems
-
Endothelial Cells / pathology*
-
Humans
-
Inflammation / immunology
-
Inflammation / pathology
-
Lung / pathology*
-
Pandemics
-
Pericytes / pathology
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / pathology*